Pathological Characteristics of Basal Cell Carcinoma

NCT ID: NCT05267691

Last Updated: 2022-07-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

50 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-01-01

Study Completion Date

2022-10-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A hospital based cross-sectional study was conducted from 2017 to February 2021. Clinical history, examination and histopathological variants were collected from medical files and pathology reports. Confirmation of pathology was done in all the patients visiting skin and plastic surgery department with suspected lesions.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Some cases may be tested for immunohistochemistry on the tissue block

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dermatological Tumors

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

sun-protected

All patients with basal cell carcinoma in a sun protected body site

Excision

Intervention Type PROCEDURE

Surgical excision of the lesion and histopathology evaluation using Hematoxylin and Eosin stains

sun-exposed

All patients with basal cell carcinoma in a sun exposed body site

Excision

Intervention Type PROCEDURE

Surgical excision of the lesion and histopathology evaluation using Hematoxylin and Eosin stains

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Excision

Surgical excision of the lesion and histopathology evaluation using Hematoxylin and Eosin stains

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Excised lesion
* Confirmed basal cell carcinoma pathologically

Exclusion Criteria

* Incision biopsy
* Incomplete follow up
Minimum Eligible Age

10 Years

Maximum Eligible Age

100 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Al-Azhar University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Abdulkarim Hasan

Laboratory coordinator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Abdulkarim Hasan

Role: PRINCIPAL_INVESTIGATOR

Al-Azhar University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Abdulkarim Hasan

Cairo, , Egypt

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Abdulkarim Hasan, MD

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Abdulkarim A Mohammed

Role: primary

01281982245

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

AUH2201002

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

BCC Excision Revisited
NCT05853315 COMPLETED